NCT00456794View on ClinicalTrials.gov

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

PHASE2CompletedINTERVENTIONAL

Enrollment

325

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Parkinson's Disease

Interventions

DRUG

Istradefylline (KW-6002)

Trial Locations (1)

08540

Contact Kyowa Pharmaceutical, Inc., Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.

All Listed Sponsors

lead

Kyowa Kirin, Inc.

INDUSTRY